Millions of Actos Patients Show: Risk of Bladder Cancer Significant

What do more than 1,000,000 diabetes patients have in common? They were all prescribed Actos (pioglitazone) and participated in a wide-ranging study which definitively showed that the medication designed to protect them from the risks of diabetes exposed them to fatal risks of bladder cancer. The study found that when taken beyond one year, Actos patients experienced a considerable spike in the likelihood that their pioglitazone treatments would cause cancer cells to develop in their bladder. These Actos findings led the FDA to issue a disconcerting warning this summer as well as leading countries to ban Actos all together. Has your physician spoken to you about the risks associated with your Actos prescription? If you remain unaware about the risks of Actos, the time to learn about them is now! Fortunately for the victims of Actos, the leading attorneys at Fears Nachawati are preparing a lawsuit designed to protect their rights. If you suffer from Actos-related injuries, including bladder cancer, you should contact our experts immediately. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com.

Read more detail on Recent Products Liability Posts –

Legal notice about the Millions of Actos Patients Show: Risk of Bladder Cancer Significant rubric : Hukuki Net Legal News is not responsible for the privacy statements or other content from Web sites outside of the Hukuki.net site. Please refer the progenitor link to check the legal entity of this resource hereinabove.

Do you need High Quality Legal documents or forms related to Millions of Actos Patients Show: Risk of Bladder Cancer Significant?

This entry was posted in Products Liability and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply